GORE® Septal Occluder Device for Patent Foramen Ovale (PFO) Closure in Stroke Patients
NCT00738894 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 664
Last updated 2020-11-20
Summary
The primary objective is to determine if patent foramen ovale (PFO) closure with the GORE® HELEX® Septal Occluder or GORE® CARDIOFORM Septal Occluder plus antiplatelet medical management is safe and effective and reduces the risk of recurrent stroke or imaging-confirmed transient ischemic attack (TIA) when compared to antiplatelet medical management alone in patients with a PFO and history of cryptogenic stroke or imaging-confirmed TIA.
A co-primary objective is to demonstrate that medical management plus closure with the study device reduces the risk of new brain infarct compared to medical management alone.
Conditions
- Stroke
- Transient Ischemic Attack
Interventions
- DEVICE
-
Septal Occluder Device
PFO closure with study septal occluder device
- DRUG
-
Antiplatelet Medical Therapy
Investigator's choice of one of three regimen options specified in protocol
Sponsors & Collaborators
-
W.L.Gore & Associates
lead INDUSTRY
Principal Investigators
-
Scott E. Kasner, MD, FAHA · University of Pennsylvania Medical Center
-
John F. Rhodes, MD · Medical University of South Carolina
-
Lars Søndergaard, MD · Rigshospitalet, Denmark
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-12-10
- Primary Completion
- 2017-04-24
- Completion
- 2020-05-11
Countries
- United States
- Denmark
Study Locations
More Related Trials
-
The Effect of Device Closure of Patent Foramen Ovale in Elderly Patients With Crytogenic Stoke/TCI
NCT01018355 ·Status: TERMINATED ·Phase: NA
-
Procedural Success and Safety of the Nit-Occlud® Patent Foramen Ovale (PFO) Closure Device and Its Application System
NCT00968032 ·Status: COMPLETED ·Phase: NA
-
Standardized Goal-Directed vs. Self-Directed Valsalva Maneuver for the Assessment of Patent Foramen Ovale
NCT06670781 ·Status: RECRUITING ·Phase: NA
-
Safety and Effectiveness Study of the Solysafe Septal Occluder in Patients With Atrial Septum Defect and Patent Foramen Ovale
NCT00207376 ·Status: COMPLETED ·Phase: NA
-
PC-Trial: Patent Foramen Ovale and Cryptogenic Embolism
NCT00166257 ·Status: UNKNOWN ·Phase: PHASE4
-
Safety and Efficacy of the Percutaneous Transvenous Mitral Annuloplasty Device to Reduce Mitral Regurgitation
NCT00568230 ·Status: COMPLETED ·Phase: PHASE1
-
Long-term Outcomes After Percutaneous Closure of PFO
NCT05558774 ·Status: UNKNOWN
-
Evaluation of the Efficacy and Safety of a Simplified Procedure for the Percutaneous Closure of the Patent Foramen Ovale
NCT03828825 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Endoscopic Closure of Tracheoesophageal Fistulas With Occluder Device
NCT01153061 ·Status: TERMINATED ·Phase: PHASE4
-
Early Feasibility Study for the Foldax TRIA Mitral Heart Valve Replacement
NCT04717570 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
MitraClip® and Hemodynamic Effects of Relevant Iatrogenic Atrial Septum Defect Closure
NCT03024268 ·Status: UNKNOWN ·Phase: NA
-
CorMatrix Cor TRICUSPID ECM Valve Replacement Study
NCT02397668 ·Status: RECRUITING ·Phase: NA
-
EXPLORE MRace: Early Feasibility Experience of Posterior Leaflet Restoration to Reduce Mitral Regurgitation Using the MRace Implant
NCT06113354 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Safety and Feasibility Study: Transcatheter Valve Repair in Severe Symptomatic Functional Tricuspid Regurgitation
NCT07140562 ·Status: RECRUITING ·Phase: NA
-
AHEAD: European Feasibility Study of the Cardiovalve Transfemoral Mitral Valve System
NCT03339115 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Clinical Evaluation of the Safety and Effectiveness of the MitraClip System in the Treatment of Clinically Significant Functional Mitral Regurgitation
NCT02444338 ·Status: COMPLETED ·Phase: NA
-
Study of Safety and Efficacy of the Percutaneous Reduction of Mitral Valve Regurgitation in Heart Failure Patients
NCT00787293 ·Status: SUSPENDED ·Phase: PHASE2
-
Study of Reduced Anti-coagulation/Anti-platelet Therapy in Patients With the HeartMate II Left Ventricular Assist System (LVAS) (TRACE)
NCT01477528 ·Status: COMPLETED
-
Safety and Performance of the Trialign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS)
NCT03225612 ·Status: UNKNOWN ·Phase: NA
-
Aachen Safety and Efficacy of the Percutaneous Transvenous Mitral Annuloplasty Device to Reduce Mitral Regurgitation
NCT00572091 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
CorMatrix Cor TRICUSPID ECM Valve Replacement - Pivotal Study
NCT05742906 ·Status: RECRUITING ·Phase: NA
-
Pediatric REPlAcement of the PulmonaRy ValvE in Tetralogy of Fallot -
NCT03634072 ·Status: TERMINATED ·Phase: NA
-
The Effect on EPCs by Successful Cardiac Occlusion Device Implantation
NCT02957201 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in High Risk and Very High Risk Subjects Who Need Aortic Valve Replacement
NCT01240902 ·Status: COMPLETED ·Phase: NA
-
A Multicenter, Randomized, Controlled Study to Assess Mitral vAlve reconsTrucTion for advancEd Insufficiency of Functional or iscHemic ORigiN
NCT02371512 ·Status: UNKNOWN ·Phase: NA